DINGDANG HEALTH (09886) released its annual performance report. Shareholders' net loss was 49.018 million yuan, a decrease of 87.0% year-on-year.

DINGDANG HEALTH (09886) released its annual results for the year ending December 31, 2025, with revenue of 4.88 billion yuan, a year-on-year increase of 4.7%; shareholders' net loss was 49.018 million yuan, a year-on-year decrease of 87.0%; basic loss per share was 0.04 yuan. The announcement stated that the increase in total revenue was mainly due to the revenue from pharmaceutical and medical health business increasing from 45.4 billion yuan in the year ending December 31, 2024, to 47.45 billion yuan in the year ending December 31, 2025, an increase of 4.5%. The increase in revenue from pharmaceutical and medical health business was mainly due to the improvement of the intelligent pharmacy network and the enrichment of product categories.